Video

Danielle Friedman on a Study of Diabetes Among Childhood Cancer Survivors

Author(s):

Danielle Novetsky Friedman

CURE spoke to Friedman during the 2016 Cancer Survivorship Symposium in mid-January.

Danielle Novetsky Friedman, a general pediatrician in the Pediatric Long-Term Follow-Up Program at Memorial Sloan Kettering Cancer Center, discusses a study that sought to determine the mechanisms leading to abnormal glucose and insulin dynamics in survivors of childhood cancers. We spoke with Friedman during the 2016 Cancer Survivorship Symposium in mid-January.

Read more about the study here >>

Newsletter

Stay up to date on cancer updates, research and education

Subscribe Now!
Related Videos
Image of doctor.
Image of man with black hair.
Picture of Dr. Pouneh Razavi
Richard Winneker gathers input from patients and researchers to shape MPN research, aiming to fund strategic projects for this population.
Dr. Curtiland Deville Jr. discusses the importance of crafting an individualized treatment plan for patients with prostate cancer.
Image of Crispino
Image of Dr. Reznick
Picture of Joy Anderson
Some patients with relapsed/refractory diffuse large B-cell lymphoma whose disease progressed after CAR-T cell therapy, responded to odronextamab.
Anne M. Reb is a nurse practitioner with City of Hope.
Related Content
From left: JILL REESE, M.S., APRN, AGCNS-BC, OCN, and SUSIE MALONEY, M.S., APRN, AOCN, AOCNS
April 27th 2025

Healer, Mentor and Leader

Susie Maloney, M.S., APRN, AOCN, AOCNS
Reflecting upon my relationship with Jill over the past 25 years, I am in awe of all she has accomplished.
cancer horizons logo: a white microphone on a navy blue background
March 11th 2024

Oncology Approvals, Psychological Outcomes for Survivors and an Ovarian Cancer Vaccine

Alex Biese Brielle Benyon
Last week we saw some FDA approvals come through, as well as research that explored the psychosocial outcomes of individuals who survived pediatric rhabdosarcoma.
From left: KATHLEEN COUGHLIN, M.S.N., ANP-BC, BMTCN, and ANTONIA MALONEY, B.S.N., RN, OCN
April 24th 2025

The Fearless Patient Advocate

Antonia Maloney, BSN, RN, OSN
Kathleen Coughlin, although small in stature, is often referred to as the “Bulldozer.”
Guidelines for Childhood Neuroblastoma, FDA Decisions and More
February 12th 2024

Guidelines for Childhood Neuroblastoma, FDA Decisions and More

Alex Biese Brielle Benyon
Last week, we saw a few moving parts in the regulatory space, from new NCCN guidelines for pediatric neuroblastoma treatment to FDA Fast Tracks and Priority Reviews
The journey that led to the creation of the Extraordinary Healer Award for Oncology Nursing began with a simple, yet profound, observation: © stock.adobe.com.
April 19th 2025

Illuminating Compassion in Cancer Care

Mike Hennessy Jr.
The journey that led to the creation of the Extraordinary Healer Award for Oncology Nursing began with a simple, yet profound, observation.
Illustration of giant cell.
April 17th 2025

Emactuzumab Gets Fast Track Designation in Tenosynovial Giant Cell Tumors

Ryan Scott
Emactuzumab has received fast track designation from the U.S. FDA for patients with tenosynovial giant cell tumors and who would not benefit from surgery.